NLRP3 and ischemia: Various studies using different approaches such as gene deletion [5], fasting [6] or antibody application [7] against NLRP3 highlighted a marked improvement of the post-ischemic inflammatory status and motor functions, which significantly reduced the infarct sizes in rodent ischemia models.